Synopsis
Visceral pain is pain that results from the activation of nociceptors of the thoracic, pelvic, or abdominal viscera (organs). Visceral structures are highly sensitive to distension (stretch), ischemia and inflammation, but relatively insensitive to other stimuli that normally evoke pain such as cutting or burning. Visceral pain is diffuse, difficult to localize and often referred to a distant, usually superficial, structure. It may be accompanied by symptoms such as nausea, vomiting, changes in vital signs as well as emotional manifestations. The pain may be described as sickening, deep, squeezing, and dull. Distinct structural lesions or biochemical abnormalities explain this type of pain in only a proportion of patients. These diseases are grouped under gastrointestinal neuromuscular diseases (GINMD). Others can experience visceral pains, often very intense in nature, without any evidence of structural, biochemical or histolopathologic reason for such symptoms. These diseases are grouped under functional gastrointestinal disorders (FGID) and the pathophysiology and treatment can vary greatly from GINMD. The two major single entities among functional disorders of the gut are functional dyspepsia and irritable bowel syndrome.
The global Visceral Pain market size is expected to reach US$ 1315.3 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Visceral Pain in various end use industries. The expanding demands from the Interstitial Cystitis, Crohn’s, Irritable Bowel and Chronic Prostatitis, are propelling Visceral Pain market. Analgesics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pain Modifiers segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Visceral Pain, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Visceral Pain market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Visceral Pain market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Visceral Pain sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Visceral Pain covered in this report include Pfizer, Johnson & Johnson, Abbvie, Takeda, Allergan and AstraZeneca, etc.
The global Visceral Pain market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Johnson & Johnson
Abbvie
Takeda
Allergan
AstraZeneca
Global Visceral Pain market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Visceral Pain market, Segment by Type:
Analgesics
Pain Modifiers
Global Visceral Pain market, by Application
Interstitial Cystitis
Crohn’s
Irritable Bowel
Chronic Prostatitis
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Visceral Pain companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Visceral Pain
1.1 Visceral Pain Market Overview
1.1.1 Visceral Pain Product Scope
1.1.2 Visceral Pain Market Status and Outlook
1.2 Global Visceral Pain Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Visceral Pain Market Size by Region (2018-2029)
1.4 Global Visceral Pain Historic Market Size by Region (2018-2023)
1.5 Global Visceral Pain Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Visceral Pain Market Size (2018-2029)
1.6.1 North America Visceral Pain Market Size (2018-2029)
1.6.2 Europe Visceral Pain Market Size (2018-2029)
1.6.3 Asia-Pacific Visceral Pain Market Size (2018-2029)
1.6.4 Latin America Visceral Pain Market Size (2018-2029)
1.6.5 Middle East & Africa Visceral Pain Market Size (2018-2029)
2 Visceral Pain Market by Type
2.1 Introduction
2.1.1 Analgesics
2.1.2 Pain Modifiers
2.2 Global Visceral Pain Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Visceral Pain Historic Market Size by Type (2018-2023)
2.2.2 Global Visceral Pain Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Visceral Pain Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Visceral Pain Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Visceral Pain Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Visceral Pain Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Visceral Pain Revenue Breakdown by Type (2018-2029)
3 Visceral Pain Market Overview by Application
3.1 Introduction
3.1.1 Interstitial Cystitis
3.1.2 Crohn’s
3.1.3 Irritable Bowel
3.1.4 Chronic Prostatitis
3.2 Global Visceral Pain Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Visceral Pain Historic Market Size by Application (2018-2023)
3.2.2 Global Visceral Pain Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Visceral Pain Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Visceral Pain Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Visceral Pain Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Visceral Pain Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Visceral Pain Revenue Breakdown by Application (2018-2029)
4 Visceral Pain Competition Analysis by Players
4.1 Global Visceral Pain Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Visceral Pain as of 2022)
4.3 Date of Key Players Enter into Visceral Pain Market
4.4 Global Top Players Visceral Pain Headquarters and Area Served
4.5 Key Players Visceral Pain Product Solution and Service
4.6 Competitive Status
4.6.1 Visceral Pain Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Visceral Pain Products, Services and Solutions
5.1.4 Pfizer Visceral Pain Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Visceral Pain Products, Services and Solutions
5.2.4 Johnson & Johnson Visceral Pain Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson & Johnson Recent Developments
5.3 Abbvie
5.3.1 Abbvie Profile
5.3.2 Abbvie Main Business
5.3.3 Abbvie Visceral Pain Products, Services and Solutions
5.3.4 Abbvie Visceral Pain Revenue (US$ Million) & (2018-2023)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Visceral Pain Products, Services and Solutions
5.4.4 Takeda Visceral Pain Revenue (US$ Million) & (2018-2023)
5.4.5 Takeda Recent Developments
5.5 Allergan
5.5.1 Allergan Profile
5.5.2 Allergan Main Business
5.5.3 Allergan Visceral Pain Products, Services and Solutions
5.5.4 Allergan Visceral Pain Revenue (US$ Million) & (2018-2023)
5.5.5 Allergan Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca Visceral Pain Products, Services and Solutions
5.6.4 AstraZeneca Visceral Pain Revenue (US$ Million) & (2018-2023)
5.6.5 AstraZeneca Recent Developments
6 North America
6.1 North America Visceral Pain Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Visceral Pain Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Visceral Pain Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Visceral Pain Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Visceral Pain Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Visceral Pain Market Dynamics
11.1 Visceral Pain Industry Trends
11.2 Visceral Pain Market Drivers
11.3 Visceral Pain Market Challenges
11.4 Visceral Pain Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List